温肺化瘀定喘法联合干扰素治疗小儿呼吸道合胞病毒毛细支气管炎的临床疗效观察

Clinical observation on the therapeutic effect of the method of warming the lung,removing blood stasis and relieving asthma combined with interferon in the treatment of respiratory syncytial virus Bronchiolitis in children

目的观察在小儿呼吸道合胞病毒(Respiratory syncytial virus,RSV)毛细支气管炎治疗过程中实施温肺化瘀定喘法联合干扰素的临床应用效果.方法研究将天津市第四中心医院在2019年9月-2022年9月期间收治的小儿RSV毛细支气管炎患儿68例作为实验对象,采用随机双盲法实现患者的分组,其中接受温肺化瘀定喘法联合干扰素治疗的34例患儿作为实验组,接受干扰素治疗的34例患儿作为对比组,分析比较两组患者的治疗效果.结果治疗前两组患者症状评分并无明显差异,P>0.05;实验组患者治疗效果、治疗后症状积分、临床症状与体征改善时间、住院时间均与对比组患者存在显著性差异,P<0.05.结论在实施小儿RSV毛细支气管炎治疗的过程中联合运用温肺化瘀定喘法与干扰素是一种相对较为理想的治疗方案,有助于获得更好的治疗效果,在缩短患者临床症状、体征改善时间,提高其症状改善程度的同时减少了患者住院接受治疗的时间.

Objective To observe the clinical effect of warming lung,removing bloodst asis and relieving asthma combined with interferon in the treatment of Respiratory syncytial virus(RSV)Bronchiolitis in children.Methods A total of 68 infants with RSV Bronchiolitis admitted to our hospital between September 2019 and September 0222 were enrolled in this study,among them,34 cases were tretaed with the method of warming the lung and removing blood stasisn ad relieving asthma combined with interferon as the experimentla group,and 34 cases were treated with interferon as the control group T.he therapeutic effects of the two groups were analyzed and cmo pared.Results Before treatment,there was no significant difference in symptom scores between the two groupsP(>0.05).There were significant differences between the two groups in therapeutic effect,sympotm score,improvement time of clinical symptoms and signs,andh ospital stay P(<0.05).Conclusion In the treatment of RSV Bronchiolitis,the therapy of warmingt he lung,removing blood stasis and relieving asthma combined with interferon is a relatively ideal therapyw,hich is helpful to obtain better therapeutic effect,it can sohrten the time of clinical symptom and physical sign improvement,improve the degree of symptom improvement and reduce the time of hospitalizatoin.